Sang Moo Kang (Sang-Moo Kang)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 32

Top Topics

Respiratory Syncytial Virus

Toxoplasma Gondii

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Rong Liu, Janhavi P Natekar, Ki-Hye Kim, Heather Pathak, Noopur Bhatnagar, Jannatul Ruhan Raha, Bo Ryoung Park, Anchala Guglani, Chong Hyun Shin, Mukesh Kumar, Sang Moo Kang
Multivalent and Sequential Heterologous Spike Protein Vaccinations Effectively Induce Protective Humoral Immunity against SARS-CoV-2 Variants. Vaccines 12 (4) (2024)
Chunhong Dong, Wandi Zhu, Lai Wei, Joo Kyung Kim, Yao Ma, Sang Moo Kang, Bao-Zhong Wang
Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines. Nature communications 15 (1) (2024)
Chunhong Dong, Wandi Zhu, Lai Wei, Joo Kyung Kim, Yao Ma, Sang Moo Kang, Bao-Zhong Wang
Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines. Nature communications 15 (1) (2024)
Rong Liu, Janhavi P Natekar, Ki-Hye Kim, Heather Pathak, Noopur Bhatnagar, Jannatul Ruhan Raha, Bo Ryoung Park, Anchala Guglani, Chong Hyun Shin, Mukesh Kumar, Sang Moo Kang
Multivalent and Sequential Heterologous Spike Protein Vaccinations Effectively Induce Protective Humoral Immunity against SARS-CoV-2 Variants. Vaccines 12 (4) (2024)
Chunhong Dong, Wandi Zhu, Lai Wei, Joo Kyung Kim, Yao Ma, Sang Moo Kang, Bao-Zhong Wang
Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines. Nature communications 15 (1) (2024)
Chunhong Dong, Wandi Zhu, Lai Wei, Joo Kyung Kim, Yao Ma, Sang Moo Kang, Bao-Zhong Wang
Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines. Nature communications 15 (1) (2024)
Ipshita Menon, Smital Patil, Priyal Bagwe, Sharon Vijayanand, Akanksha Kale, Keegan Braz Gomes, Sang Moo Kang, Martin D'Souza
Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses. Vaccines 11 (4) (2023)
Noopur Bhatnagar, Ki-Hye Kim, Jeeva Subbiah, Sakinah Muhammad-Worsham, Bo Ryoung Park, Rong Liu, Phillip Grovenstein, Bao-Zhong Wang, Sang Moo Kang
Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination. Vaccines 11 (7) (2023)
Ipshita Menon, Smital Patil, Priyal Bagwe, Sharon Vijayanand, Akanksha Kale, Keegan Braz Gomes, Sang Moo Kang, Martin D'Souza
Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses. Vaccines 11 (4) (2023)
Ipshita Menon, Smital Patil, Priyal Bagwe, Sharon Vijayanand, Akanksha Kale, Keegan Braz Gomes, Sang Moo Kang, Martin D'Souza
Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses. Vaccines 11 (4) (2023)
Keegan Braz Gomes, Sharon Vijayanand, Priyal Bagwe, Ipshita Menon, Akanksha Kale, Smital Patil, Sang Moo Kang, Mohammad N Uddin, Martin J D'Souza
Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles. International journal of molecular sciences 24 (13) (2023)
Ipshita Menon, Smital Patil, Priyal Bagwe, Sharon Vijayanand, Akanksha Kale, Keegan Braz Gomes, Sang Moo Kang, Martin D'Souza
Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses. Vaccines 11 (4) (2023)
Keegan Braz Gomes, Ipshita Menon, Priyal Bagwe, Lotika Bajaj, Sang Moo Kang, Martin J D'Souza
Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery. Viruses 14 (9) (2022)
Noopur Bhatnagar, Ki-Hye Kim, Jeeva Subbiah, Bo Ryoung Park, Pengfei Wang, Harvinder Singh Gill, Bao-Zhong Wang, Sang Moo Kang
Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination. Vaccines 10 (9) (2022)
Jeeva Subbiah, Judy Oh, Ki-Hye Kim, Chong Hyun Shin, Bo Ryoung Park, Noopur Bhatnagar, Baik-Lin Seong, Bao-Zhong Wang, Sang Moo Kang
A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine. NPJ vaccines 7 (1) (2022)
Ki-Hye Kim, Zhuo Li, Noopur Bhatnagar, Jeeva Subbiah, Bo Ryoung Park, Chong Hyun Shin, Peter Pushko, Bao-Zhong Wang, Sang Moo Kang
Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle. PLoS pathogens 18 (8) (2022)
Sucheta D'Sa, Kimberly Braz Gomes, Grace Lovia Allotey-Babington, Cemil Boyoglu, Sang Moo Kang, Martin J D'Souza
Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity. Vaccines 10 (4) (2022)
Ramireddy Bommireddy, Shannon Stone, Noopur Bhatnagar, Pratima Kumari, Luis E Munoz, Judy Oh, Ki-Hye Kim, Jameson T L Berry, Kristen M Jacobsen, Lahcen Jaafar, Swe-Htet Naing, Allison N Blackerby, Tori Van der Gaag, Chloe N Wright, Lilin Lai, Christopher D Pack, Sampath Ramachandiran, Mehul S Suthar, Sang Moo Kang, Mukesh Kumar, Shaker J C Reddy, Periasamy Selvaraj
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses. Vaccines 10 (6) (2022)
Min-Ju Kim, Ki-Back Chu, Hae-Ji Kang, Keon-Woong Yoon, Gi-Deok Eom, Jie Mao, Su-Hwa Lee, Jeeva Subbiah, Sang Moo Kang, Eun-Kyung Moon, Fu-Shi Quan
Protective Immunity Induced by Immunization with Baculovirus, Virus-like Particle, and Vaccinia Virus Expressing the AMA1 of Plasmodium berghei . Biomedicines 10 (9) (2022)
Chong Hyun Shin, Ki-Hye Kim, Subbiah Jeeva, Sang Moo Kang
Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome. Cells 10 (6) (2021)
Ki-Hye Kim, Young-Tae Lee, Yoonsuh Park, Eun-Ju Ko, Yu-Jin Jung, Yu-Jin Kim, Eun-Kyeong Jo, Sang Moo Kang
BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection. Biomedicines 9 (5) (2021)
Ki-Hye Kim, Noopur Bhatnagar, Subbiah Jeeva, Judy Oh, Bo Ryoung Park, Chong Hyun Shin, Bao-Zhong Wang, Sang Moo Kang
Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice. Vaccines 9 (4) (2021)
Daria Mezhenskaya, Irina Isakova-Sivak, Tatiana Kotomina, Victoria Matyushenko, Min-Chul Kim, Noopur Bhatnagar, Ki-Hye Kim, Sang Moo Kang, Larisa Rudenko
A Strategy to Elicit M2e-Specific Antibodies Using a Recombinant H7N9 Live Attenuated Influenza Vaccine Expressing Multiple M2e Tandem Repeats. Biomedicines 9 (2) (2021)
Hye Suk Hwang, Young-Tae Lee, Ki-Hye Kim, Shun Mei Lin, Kap Seung Yang, Hoonsung Cho, Sang Moo Kang
Roles of the Fc Receptor γ-Chain in Inducing Protective Immune Responses after Heterologous Vaccination against Respiratory Syncytial Virus Infection. Vaccines 9 (3) (2021)
Kimberly Braz Gomes, Sucheta D'Sa, Grace Lovia Allotey-Babington, Sang Moo Kang, Martin J D'Souza
Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus. Vaccines 9 (11) (2021)
Subbiah Jeeva, Ki-Hye Kim, Chong Hyun Shin, Bao-Zhong Wang, Sang Moo Kang
An Update on mRNA-Based Viral Vaccines. Vaccines 9 (9) (2021)
Chau Thuy Tien Le, So Yeon Ahn, Sang Moo Kang, Eun-Ju Ko
Functional NK Cell Activation by Ovalbumin Immunization with a Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Dendritic Cell Maturation. Vaccines 9 (10) (2021)
Michal P Kuczma, Edyta A Szurek, Anna Cebula, Benoit Chassaing, Yu-Jin Jung, Sang Moo Kang, James G Fox, Bärbel Stecher, Leszek Ignatowicz
Commensal epitopes drive differentiation of colonic Tregs. Science advances 6 (16) (2020)
Eun-Ju Ko, Youri Lee, Young-Tae Lee, Hye Suk Hwang, Yoonsuh Park, Ki-Hye Kim, Sang Moo Kang
Natural Killer and CD8 T Cells Contribute to Protection by Formalin Inactivated Respiratory Syncytial Virus Vaccination under a CD4-Deficient Condition. Immune network 20 (6) (2020)
Young-Man Kwon, Hye Suk Hwang, Young-Tae Lee, Ki-Hye Kim, Youri Lee, Min-Chul Kim, Yu-Na Lee, Fu-Shi Quan, Martin L Moore, Sang Moo Kang
Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform. Immune network 19 (3) (2019)
Soojin Park, Youri Lee, Young-Man Kwon, Young-Tae Lee, Ki-Hye Kim, Eun-Ju Ko, Jae Hwan Jung, Manki Song, Barney Graham, Mark R Prausnitz, Sang Moo Kang
Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge. PloS one 13 (10) (2018)
Young-Tae Lee, Eun-Ju Ko, Youri Lee, Ki-Hye Kim, Min-Chul Kim, Yu-Na Lee, Sang Moo Kang
Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses. PloS one 13 (1) (2018)